Differences in the acute toxic effects of breast radiotherapy by fractionation schedule: Comparative analysis of physician-assessed and patient-reported outcomes in a large multicenter cohort

JAMA Oncology

Volumn 1, Issue 7, 2015, Pages 918-930

  Jagsi, Reshma ^a,b   Griffith, Kent A ^c   Boike, Thomas P ^d   Walker, Eleanor ^e   Nurushev, Teamour ^f   Grills, Inga S ^g   Moran, Jean M ^a   Feng, Mary ^a   Hayman, James ^a   Pierce, Lori J ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b Center for Bioethics and Social Sciences in Medicine   (United States)

^c UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^d McLaren NorthernMichigan ^*  (United States)

^e HENRY FORD HOSPITAL   (United States)

^f 21ST CENTURY ONCOLOGY   (United States)

^g WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT THERAPY; ADVERSE EFFECTS; AGED; BREAST NEOPLASMS; CLINICAL TRIAL; COMPARATIVE STUDY; FEMALE; HUMAN; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; PREDICTIVE VALUE; PROSPECTIVE STUDY; RADIATION DOSE FRACTIONATION; RADIATION INJURIES; RISK FACTOR; SEGMENTAL MASTECTOMY; SELF REPORT; SEVERITY OF ILLNESS INDEX; TIME; TREATMENT OUTCOME; UNITED STATES;

AGED; BREAST NEOPLASMS; DOSE FRACTIONATION; FEMALE; HUMANS; MASTECTOMY, SEGMENTAL; MICHIGAN; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RADIATION INJURIES; RADIOTHERAPY, ADJUVANT; RISK FACTORS; SELF REPORT; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 84964783451     PISSN: 23742437     EISSN: 23742445     Source Type: Journal    
DOI: 10.1001/jamaoncol.2015.2590     Document Type: Article

References (39)

1. Whelan TJ, Pignol JP, Levine MN, et al. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med. 2010; 362 (6): 513-520.
2. Haviland JS, Owen JR, Dewar JA, et al; START Trialists' Group. The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials. Lancet Oncol. 2013; 14 (11): 1086-1094.
3. Smith BD, Bentzen SM, Correa CR, et al. Fractionation for whole breast irradiation: An American Society for Radiation Oncology (ASTRO) evidence-based guideline. Int J Radiat Oncol Biol Phys. 2011; 81(1): 59-68.
4. American Society for Radiation Oncology. Ten things physicians and patients should question. http: //www.choosingwisely.org/societies/american -society-for-radiation-oncology. Accessed June 29, 2015.
5. Ashworth A, KongW, Whelan T, MackillopWJ. A population-based study of the fractionation of postlumpectomy breast radiation therapy. Int J Radiat Oncol Biol Phys. 2013; 86(1): 51-57.
6. Holloway CL, Panet-Raymond V, Olivotto I. Hypofractionation should be the new 'standard' for radiation therapy after breast conserving surgery. Breast. 2010; 19(3): 163-167.
7. National Institute for Health and Care Excellence. Early and locally advanced breast cancer: Diagnosis and treatment. 2009. http: //www.nice.org.uk /guidance/cg80. Accessed June 29, 2015.
8. van der Laan HP, Hurkmans CW, Kuten A, Westenberg HA; EORTC-ROG BreastWorking Party. Current technological clinical practice in breast radiotherapy; results of a survey in EORTC-Radiation Oncology Group affiliated institutions. Radiother Oncol. 2010; 94(3): 280-285.
9. Bekelman JE, Sylwestrzak G, Barron J, et al. Uptake and costs of hypofractionated vs conventional whole breast irradiation after breast conserving surgery in the United States, 2008-2013. JAMA. 2014; 312(23): 2542-2550.
10. Jagsi R, Griffith KA, Heimburger D, et al; Michigan Radiation Oncology Quality Consortium. Choosing wisely? patterns and correlates of the use of hypofractionated whole-breast radiation therapy in the state of Michigan. Int J Radiat Oncol Biol Phys. 2014; 90(5): 1010-1016.
11. Jagsi R, Falchook AD, Hendrix LH, Curry H, Chen RC. Adoption of hypofractionated radiation therapy for breast cancer after publication of randomized trials. Int J Radiat Oncol Biol Phys. 2014; 90(5): 1001-1009.
12. Whelan TJ, Kim DH, Sussman J. Clinical experience using hypofractionated radiation schedules in breast cancer. Semin Radiat Oncol. 2008; 18(4): 257-264.
13. Whelan T, MacKenzie R, Julian J, et al. Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer. J Natl Cancer Inst. 2002; 94(15): 1143-1150.
14. Owen JR, Ashton A, Bliss JM, et al. Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: Long-term results of a randomised trial. Lancet Oncol. 2006; 7(6): 467-471.
15. Yarnold J, Ashton A, Bliss J, et al. Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: Long-term results of a randomised trial. Radiother Oncol. 2005; 75(1): 9-17.
16. Bentzen SM, Agrawal RK, Aird EG, et al; START Trialists' Group. The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: A randomised trial. Lancet Oncol. 2008; 9 (4): 331-341.
17. Bentzen SM, Agrawal RK, Aird EG, et al; START Trialists' Group. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: A randomised trial. Lancet. 2008; 371(9618): 1098-1107.
18. FowlerFJ. Improving Survey Questions: Design and Evaluation. Thousand Oaks, CA: Sage Publications; 1995.
19. Willis GB. Cognitive Interviewing: A Tool for Improving Questionnaire Design. Thousand Oaks, CA: Sage Publications; 2005.
20. Cleeland CS, Ryan KM. Pain assessment: Global use of the Brief Pain Inventory. Ann Acad Med Singapore. 1994; 23(2): 129-138.
21. Chren MM, Lasek RJ, Quinn LM, Mostow EN, Zyzanski SJ. Skindex, a quality-of-life measure for patients with skin disease: Reliability, validity, and responsiveness. J Invest Dermatol. 1996; 107(5): 707-713.
22. Stanton AL, Krishnan L, Collins CA. Form or function? part 1. subjective cosmetic and functional correlates of quality of life in women treated with breast-conserving surgical procedures and radiotherapy. Cancer. 2001; 91(12): 2273-2281.
23. Schall R. Estimation in generalized linear models with random effects. Biometrika. 1991; 78 (4): 719-727.
24. Wolfinger R, O'ConnellM. Generalized linear mixed models: A pseudo-likelihood approach. J Stat Comput Simul. 1993; 48(3-4): 233-243.
25. Zhang H, Lu N, Feng C, et al. On fitting generalized linear mixed-effects models for binary responses using different statistical packages. Stat Med. 2011; 30(20): 2562-2572.
26. Joiner M, van der Kogel A, eds. Basic Clinical Radiobiology. 4th ed. London, England: Hodder Arnold; 2009.
27. Hall EJ, Giaccia AJ. Radiobiology for the Radiologist. 6th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2006.
28. Thames HD Jr, Withers HR, Peters LJ, Fletcher GH. Changes in early and late radiation responses with altered dose fractionation: Implications for dose-survival relationships. Int J Radiat Oncol Biol Phys. 1982; 8(2): 219-226.
29. Williams MV, Denekamp J, Fowler JF. A review of alpha/beta ratios for experimental tumors: Implications for clinical studies of altered fractionation. Int J Radiat Oncol Biol Phys. 1985; 11 (1): 87-96.
30. Agrawal RK, Alhasso A, Barrett-Lee PJ, et al; FAST Trialists group. First results of the randomised UK FAST Trial of radiotherapy hypofractionation for treatment of early breast cancer (CRUKE/04/015). Radiother Oncol. 2011; 100(1): 93-100.
31. Haislund B, Bang T, Bjorklund EllegaardM, et al. PO-0954 Acute morbidity in patients with early breast cancer in adjuvant radiotherapy in the DBCG HYPO and DBCG PBI protocols. Radiother Oncol. 2012; 103: S375-S376.
32. Li S,Wang S, Song Y, et al. Interim analysis of 354 breast cancer patients randomly treated with hyperfractionated or conventional fractionated radiation therapy after breast-conserving surgery. Int J Radiat Oncol Biol Phys. 2014; 90: S256.
33. Karmacharya R, Shah A, Jha AK, et al. A comparative study of acute toxicity between conventional and hypofractionated adjuvant radiotherapy in breast cancer. J Cancer Res Ther. 2012; 8: S145.
34. Patni N, Jain M, Patni S, et al. A comparison of acute and chronic toxicity profile between conventional and hypofractionated whole breast irradiation in patients undergoing breast conserving surgery. Int J Radiat Oncol Biol Phys. 2012; 84: S232.
35. Shaitelman SF, Buchholz TA, Hunt KK, et al. Hypofractionated whole breast irradiation results in less acute toxicity and improved quality of life at 6 months compared to conventionally fractionated whole breast irradiation: Results of a randomized trial. Paper presented at: ASTRO's 56th Annual Meeting, Targeting Cancer: Technology & Biology; September 14, 2014; San Francisco, CA.
36. Walker GV, Giordano SH, Williams M, et al. Muddywater? variation in reporting receipt of breast cancer radiation therapy by population-based tumor registries. Int J Radiat Oncol Biol Phys. 2013; 86(4): 686-693.
37. Jagsi R, Abrahamse P, Hawley ST, Graff JJ, Hamilton AS, Katz SJ. Underascertainment of radiotherapy receipt in Surveillance, Epidemiology, and End Results registry data. Cancer. 2012; 118(2): 333-341.
38. Palta JR, Efstathiou JA, Bekelman JE, et al. Developing a national radiation oncology registry: From acorns to oaks. Pract Radiat Oncol. 2012; 2(1): 10-17.
39. Wang EH, Mougalian SS, Soulos PR, et al. Adoption of hypofractionated whole-breast irradiation for early-stage breast cancer: A National Cancer Data Base analysis. Int J Radiat Oncol Biol Phys. 2014; 90(5): 993-1000.